US Patent Issued to DiaMedica USA on Sept. 8 for "Ulinastatin polypeptides" (Minnesota, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,233, issued on Sept. 8, was assigned to DiaMedica USA Inc..

"Ulinastatin polypeptides" was invented by Rick Pauls (Minneapolis), Todd Verdoorn (Minnetonka, Minn.), Karl Frank Johnson (Waunakee, Wis.) and Gregory Thomas Bleck (Cross Plains, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are ulinastatin glycoforms, ulinastatin fusion polypeptides, and related compositions, mixtures, and methods of use, including methods of recombinantly producing ulinastatin polypeptides and treating diseases."

The patent was filed on June 21, 2023, under Application No. 18/338,970.

*For further information, including images, charts and tables, please ...